Ultimas

Second SISAQOL-IMI Consensus Meeting

2025-03-12T15:40:56+01:00

Second SISAQOL-IMI Consensus Meeting2025-03-12T15:40:56+01:00

Standardizing the design, analysis, and interpretation of patient-reported outcomes in cancer clinical trials

2025-03-12T15:41:49+01:00

Standardizing the design, analysis, and interpretation of patient-reported outcomes in cancer clinical trials2025-03-12T15:41:49+01:00

PRESS RELEASE: Generating recommendations for the design, analysis and interpretation of patient- reported outcome (PRO) data for cancer clinical trials: the launch of SISAQOL-IMI

2025-03-12T15:42:37+01:00

PRESS RELEASE: Generating recommendations for the design, analysis and interpretation of patient- reported outcome (PRO) data for cancer clinical trials: the launch of SISAQOL-IMI2025-03-12T15:42:37+01:00

Collaborating for consensus

2025-03-12T15:43:56+01:00

Collaborating for consensus2025-03-12T15:43:56+01:00

Kick off press release for SISAQOL-IMI

2025-03-12T15:44:33+01:00

Kick off press release for SISAQOL-IMI2025-03-12T15:44:33+01:00

The SISAQOL-IMI Project has received funding from the Innovative Health Initiative 2 joint undertaking under grant agreement No 945052. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.